Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.
Third-Quarter 2012 Financial Reports Show Novartis and Merck Down
October 30th 2012Pharmaceutical industry leaders Novartis and Merck-among others-released second-quarter 2012 results showing global sales down in third-quarter 2012, with growth in key pharmaceutical products helping to offset losses due to patent expirations.
Improving Intelligent Device Management
October 17th 2012Strategic management of intelligent devices is important in any processing field, and a new standards committee at the International Society of Automation aims to provide direction so that manufacturers can better utilize the devices' capabilities.
Hot Melt Extrusion Research Continues
October 10th 2012Research into hot melt extrusion (HME) as a solution to improve solubility continues to expand with a partnership between Encap Drug Delivery, a contract development and manufacturing organization in the UK, and the School of Pharmacy at the Queen’s University Belfast (QUB), announced in a press release this week.
Bayer HealthCare Acquires Teva's US Animal Health Business
September 18th 2012Teva announced an agreement in which Bayer HealthCare will acquire the US-based animal health business of Teva Pharmaceutical Industries for up to $145 million. The transaction is expected to close in 2013, subject to antitrust clearance and other conditions.
Winds of Change at the International Society of Automation Summit
August 29th 2012The International Society of Automation’s (ISA’s) 7th Marketing and Sales Summit, held Aug. 15–17, 2012 in Austin, Texas, was themed “New Rules of Customer Engagement: Riding the Winds of Change”, and emphasized the need to adapt to the changing needs, expectations, and behaviors of marketplace decision makers, according to an Aug. 27, 2012 press release.
ISPE Issues Guidance for Packaging, Labeling, and Warehousing Facilities
July 9th 2012ISPE has issued a guidance that is intended to help companies meet cGMP requirements for packaging, labeling, and warehousing facilities and avoid problems such as product adulteration, product mix-up, label mix-up, and misbranding.
Seminar Addresses Developments and Challenges in Hot Melt Extrusion
June 25th 2012Development in hot melt extrusion (HME) using twin-screw extruders to make solid-dosage drug forms has increased significantly in the past decade, although it is still in its infancy, said Charlie Martin, president of the US operations of Leistritz at the recent Pharmaceutical Extrusion Seminar organized by the company.